Stéphane Priet

3.0k citations
39 papers · 1.8k indexed · 1 hit paper · h-index 20

Impact in

  • Virology top 1%
    • HIV Research and Treatment
    • HIV/AIDS drug development and treatment
    • Viral Infections and Vectors

Papers in

    • HIV Research and Treatment 12
    • HIV/AIDS drug development and treatment 13
    • Viral Infections and Vectors 9

Stéphane Priet

39 papers receiving 1.8k citations

Hit Papers

SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates 2012 · 671 citations
6712012202620162021200400600

Peers

Stéphane Priet
Comparison fields: 5 of 97
  • Virology 740
  • Infectious Diseases 641
  • Immunology 434
  • Epidemiology 362
  • Public Health, Environmental and Occupational Health 289
Replace Ma Luo with:
Ma Luo Canada
Isabelle Staropoli France
Anjali Joshi United States
Kavita Singh India
Carmen Gómez Spain
Eleftherios Michailidis United States
Christina M. Stürzel Germany
Nir Paran Israel
Nicoletta Casartelli France
Thomas Gramberg Germany
Stéphane Priet relative to Ma Luo Canada Ma Luo's profile →
Citations per field
00.5×1.5×2.0×
Ma Luo · 1×
Citations per year

Countries citing papers authored by Stéphane Priet

Since Specialization
Citations

This map shows the geographic impact of Stéphane Priet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Priet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Priet more than expected).

Fields of papers citing papers by Stéphane Priet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Priet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Priet. The network helps show where Stéphane Priet may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stéphane Priet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stéphane Priet Line = papers co-authored together Stéphane Priet links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20214
2 202125
3 20196
4 201844
5 201719
6 201511
7 201474
8
SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates
Hit paper breakdown →
2012671
9 201266
10 20117
11 20098
12 2008160
13 200841
14 200584
15 200533
16 200322
17 200319
18 200315
19 200331
20 20019

About Stéphane Priet

Stéphane Priet is a scholar working on Virology, Infectious Diseases, Modeling and Simulation, Epidemiology and Hepatology, having authored 39 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (13 papers), HIV Research and Treatment (12 papers), Mosquito-borne diseases and control (9 papers), Viral Infections and Vectors (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Cytomegalovirus and herpesvirus research (6 papers), Biochemical and Molecular Research (4 papers) and Herpesvirus Infections and Treatments (3 papers). The work is most often cited by research in Virology (740 citations), Infectious Diseases (641 citations), Immunology (434 citations), Epidemiology (362 citations) and Public Health, Environmental and Occupational Health (289 citations). Stéphane Priet has collaborated with scholars based in France, Germany and Belgium. Frequent co-authors include Bruno Canard, Gilles Quérat, Joséphine Sire, Cécile Esnault, Baek Kim, Thomas Gramberg, Claire Maudet, Loïc Dragin, Florence Margottin-Goguet and Nathaniel R. Landau. Their work appears in journals such as Scientific Reports, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Journal of Biological Chemistry and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026